Open Access<p>Bevacizumab in Combination with Pemetrexed and Platinum Significantly Improved the Clinical Outcome of Patients with Advanced Adenocarcinoma NSCLC and Brain Metastases</p>
Author(s) -
Yaru Tian,
Xuechao Zhai,
Hao Tian,
Jing Wang,
Hui Zhu,
Jinming Yu
Publication year - 2019
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s222910
Subject(s) - bevacizumab , pemetrexed , medicine , oncology , regimen , lung cancer , adenocarcinoma , chemotherapy , asymptomatic , progression free survival , gastroenterology , cancer , cisplatin
The study aims to evaluate the clinical efficacy and safety of bevacizumab in combination with the first-line pemetrexed-platinum (PP) in patients with advanced adenocarcinoma non-small-cell lung cancer (NSCLC) and brain metastases.